Login to Your Account

Amgen Partners with Teijin in Pursuit of Bold Asia Plan

By Shannon Ellis
Staff Writer

Wednesday, August 7, 2013
SHANGHAI – Still avoiding discussion of its failed bid for Onyx Pharmaceuticals Inc. in June, Amgen Inc. continues to implement an ambitious Asia expansion strategy when it announced the launch of a new collaboration with Japan's Teijin Pharma Ltd. to search for new therapies for autoimmune diseases.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription